buserelin has been researched along with Hypergonadotropic Hypogonadism in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (45.45) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, H; Nakamura, T; Suzuki, H; Tanaka, M; Watanabe, N; Yoshida, A | 1 |
| Kershaw-Young, CM; Khalid, M; McGowan, MR; Pitsillides, AA; Scaramuzzi, RJ; Wheeler-Jones, CP | 1 |
| Aguilar-Rojas, A; Conn, PM; Janovick, JA; Jardón-Valadez, E; Leaños-Miranda, A; Maya-Núñez, G; Ulloa-Aguirre, A; Zariñan, T | 1 |
| Carluccio, A; Contri, A; Gloria, A; Wegher, L | 1 |
| Conn, PM; Janovick, JA; Leaños-Miranda, A | 1 |
| Cutfield, WS; Hofman, PL; McGrail, CE; Miles, HL; Unwin, KE; Wilson, DA | 1 |
| Lanes, R | 1 |
| Sandow, J | 1 |
| Klaushofer, G; Stackl, W; Vierhapper, H; Waldhäusl, W | 1 |
| Donald, RA; Espiner, EA; Moore, MP; Smith, R; Stronach, S | 1 |
| Fournier, M; Mazenod, B; Morel, Y; Mornex, R; Tourniaire, J | 1 |
| Baird, DT; McNeilly, AS; Vaughan Williams, CA | 1 |
| Franks, S; Gilling-Smith, C | 1 |
| Loumaye, E; Shoham, Z; Weissman, A | 1 |
| Conn, PM; Janovick, JA; Maya-Nunez, G | 1 |
| Bennett, MK; Clayton, RN; Cox, BS; Craven, R; Furr, BJ; Grocock, CA; Harrison, CJ; O'Shaughnessy, PJ; Porter-Goff, AE; Scott, IS | 1 |
| Bettendorf, G; Braendle, W; Lichtenberg, V; Lindner, C | 2 |
| Coutts, JR; Fleming, R | 1 |
| Burger, HG; Healy, DL; McLachlan, RI | 1 |
| Calogero, A; Coniglione, F; D'Agata, R; Macchi, M; Mongioi, A; Recupero, D; Sipione, C; Vicari, E | 1 |
| Hesp, R; Katz, D; Matta, WH; Shaw, RW | 1 |
3 review(s) available for buserelin and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
Clinical applications of LHRH and its analogues.
Topics: Adolescent; Adult; Animals; Buserelin; Climacteric; Contraception; Corpus Luteum; Cryptorchidism; Female; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Ovulation; Pituitary Gland; Prostatic Neoplasms; Puberty, Delayed; Puberty, Precocious; Rats; Testis | 1983 |
Advances in induction of ovulation.
Topics: Buserelin; Clinical Trials as Topic; Clomiphene; Drug Administration Schedule; Drug Resistance; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Growth Hormone; Humans; Hypogonadism; Naltrexone; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome | 1994 |
Clinical aspects of LHRH analogues in gynaecology: a review.
Topics: Adolescent; Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Infertility, Female; Leiomyoma; Menstruation Disturbances; Pituitary Gland; Polycystic Ovary Syndrome; Uterine Neoplasms | 1986 |
4 trial(s) available for buserelin and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
The effect of estradiol on COX-2, EP2, and EP4 mRNA expression and the extracellular matrix in the cervix of the hypogonadotrophic, ovariectomized ewe.
Topics: Animals; Buserelin; Cervix Uteri; Cyclooxygenase 2; Estradiol; Extracellular Matrix; Female; Gene Expression; Hypogonadism; Infusion Pumps, Implantable; Injections, Intramuscular; Ovariectomy; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; RNA, Messenger; Sheep | 2010 |
Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty.
Topics: Adolescent; Adult; Body Mass Index; Buserelin; Cohort Studies; Diagnostic Techniques, Endocrine; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Growth Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; New Zealand; Predictive Value of Tests; Puberty, Delayed; Testosterone; Treatment Outcome | 2006 |
Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Buserelin; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Corpus Luteum; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Hypogonadism; Infertility, Female; Luteinizing Hormone; Menotropins; Ovulation Induction; Pregnancy; Progesterone | 1996 |
Clinical aspects of LHRH analogues in gynaecology: a review.
Topics: Adolescent; Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Infertility, Female; Leiomyoma; Menstruation Disturbances; Pituitary Gland; Polycystic Ovary Syndrome; Uterine Neoplasms | 1986 |
16 other study(ies) available for buserelin and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
A man with hypogonadotropic hypogonadism successfully treated with nasal administration of the low-dose gonadotropin-releasing hormone analog buserelin.
Topics: Administration, Intranasal; Adult; Buserelin; Dose-Response Relationship, Drug; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hypogonadism; Infertility, Male; Male; Semen Analysis; Testosterone; Treatment Outcome | 2009 |
Biochemical mechanism of pathogenesis of human gonadotropin-releasing hormone receptor mutants Thr104Ile and Tyr108Cys associated with familial hypogonadotropic hypogonadism.
Topics: Binding, Competitive; Buserelin; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Hypogonadism; Inhibitory Concentration 50; Inositol Phosphates; Molecular Dynamics Simulation; Mutation, Missense; Protein Binding; Protein Interaction Domains and Motifs; Receptors, LHRH | 2011 |
Successful use of a gonadotropin-releasing hormone (GnRH) analog for the treatment of tertiary hypogonadism (GnRH deficiency) in a 5-year-old Belgian Blue bull.
Topics: Animals; Buserelin; Cattle; Cattle Diseases; Gonadotropin-Releasing Hormone; Hypogonadism; Infusion Pumps, Implantable; Male; Time Factors | 2012 |
Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadism.
Topics: Animals; Biological Transport; Buserelin; COS Cells; Hypogonadism; Inositol Phosphates; Mutation; Mutation, Missense; Protein Folding; Receptors, LHRH; Transfection | 2002 |
A GnRH analog test in diagnosing gonadotropin deficiency in males with delayed puberty.
Topics: Buserelin; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Growth Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Puberty, Delayed; Testosterone | 2006 |
Serum concentrations of gonadotrophins in hypergonadotrophic patients following stimulation by a long-acting analogue of luteinizing hormone-releasing hormone.
Topics: Aged; Buserelin; Castration; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Klinefelter Syndrome; Luteinizing Hormone; Male; Middle Aged; Testis | 1983 |
The effects of different dose regimes of D-SER(TBU)6-LHRH-EA10 (HOE 766) in subjects with hypogonadotrophic hypogonadism.
Topics: Adolescent; Adult; Buserelin; Drug Administration Schedule; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Luteinizing Hormone; Male; Testosterone | 1981 |
Treatment of hypogonadotropic hypogonadal male patients with the luteinizing hormone-relasing hormone (LH-RH) anolog D-Ser(TBU)6 EA10 LH-RH: transient disappearance of gonadotropin stimulation.
Topics: Adolescent; Adult; Antibodies; Buserelin; Chorionic Gonadotropin; Drug Administration Schedule; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Pituitary Gland; Stimulation, Chemical; Testosterone | 1982 |
Assessment of pituitary secretory capacity in women with hypogonadotrophic hypogonadism by using a long-acting synthetic analogue of luteinizing hormone releasing factor.
Topics: Buserelin; Drug Administration Schedule; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Luteinizing Hormone; Pituitary Gland | 1982 |
Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Buserelin; COS Cells; Humans; Hypogonadism; Indoles; Mutation; Protein Folding; Pyridines; Receptors, LHRH; Templates, Genetic | 2002 |
Effects of the gonadotrophin-releasing hormone agonist 'Zoladex' upon pituitary and gonadal function in hypogonadal (hpg) male mice: a comparison with normal male and testicular feminized (tfm) mice.
Topics: Androgens; Animals; Buserelin; Feminization; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Goserelin; Hypogonadism; Luteinizing Hormone; Male; Mice; Orchiectomy; Organ Size; Pituitary Gland; Reference Values; Testis | 1992 |
Induction of pharmacological hypogonadotropism using gonadotropin-releasing hormone agonists in patients undergoing controlled ovarian stimulation.
Topics: Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Luteinizing Hormone; Ovary; Pituitary Gland; Prolactin; Testosterone; Triptorelin Pamoate | 1990 |
[Combined GnRH agonist/hMG therapy and ovarian overstimulation syndrome].
Topics: Buserelin; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Infertility, Female; Menotropins; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 1989 |
Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression.
Topics: Buserelin; Chorionic Gonadotropin; Corpus Luteum; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Menotropins; Menstrual Cycle; Ovarian Follicle; Progesterone; Ultrasonography | 1986 |
Failure of GnRH analogue to inhibit serum concentrations of testosterone and 17 alpha-hydroxyprogesterone in hCG-substituted hypogonadotropic hypogonadism.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Buserelin; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Humans; Hydroxyprogesterones; Hypogonadism; Male; Testis; Testosterone | 1986 |
Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.
Topics: Absorptiometry, Photon; Adult; Bone and Bones; Buserelin; Female; Femur; Humans; Hypogonadism; Lumbar Vertebrae; Menopause; Tomography, X-Ray Computed | 1987 |